Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dana Z. Awwad
Interleukin-15 and [Alpha](1,3)galactosyl-Expressing Vaccine Combination Therapy for Melanoma
Related publications
Combination Therapy With BRAF and MEK Inhibitors for Melanoma: Latest Evidence and Place in Therapy
Therapeutic Advances in Medical Oncology
Oncology
Combination Therapy Targeting the Elevated Interleukin-6 Level Reduces Invasive Migration of BRAF Inhibitor-Resistant Melanoma Cells
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Combination Immunotherapy for Melanoma
JAMA Oncology
Cancer Research
Oncology
High Antitumor Activity of RLI, an Interleukin-15 (IL-15)-IL-15 Receptor Fusion Protein, in Metastatic Melanoma and Colorectal Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Combination Therapy With F5/35 Fiber Chimeric Conditionally Replicative Adenoviruses Expressing IL-24 Enhances the Antitumor Effect of Temozolomide Against Melanoma
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Combination of Immunotherapy With Targeted Therapy: Theory and Practice in Metastatic Melanoma
Frontiers in Immunology
Allergy
Immunology
Role of Interleukin-6 and Interleukin-15 in Exercise
MOJ Immunology
Interleukin and Interleukin Receptor Gene Polymorphisms and Susceptibility to Melanoma
Melanoma Research
Dermatology
Cancer Research
Oncology
Melanoma Therapy With Rhenium-Cyclized Alpha Melanocyte Stimulating Hormone Peptide Analogs